Beta Bionics, Inc. (BBNX) Financials

BBNX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 304.4 million 33.2 million
Dec. 31, 2025 328.7 million 41.1 million
Sept. 30, 2025 330.0 million 35.3 million
June 30, 2025 330.0 million 28.3 million

BBNX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -25.2 million 5.4 million
Dec. 31, 2025 -10.5 million 4.3 million
Sept. 30, 2025 -10.0 million 4.5 million
June 30, 2025 -15.4 million 4.8 million

BBNX Net Income

No data available :(

BBNX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 199.5 million - 6.9 million
Dec. 31, 2025 219.1 million - 7.3 million
Sept. 30, 2025 228.7 million - 7.7 million
June 30, 2025 249.7 million - 5.2 million

BBNX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 44.4 million
Dec. 31, 2025 40.5 million
Sept. 30, 2025 43.6 million
June 30, 2025 43.4 million

BBNX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.4 million 10.4 million 30.4 million 20.7 million
Dec. 31, 2025 1.9 million 10.1 million 24.9 million 16.3 million
Sept. 30, 2025 1.3 million 8.2 million 24.0 million 16.0 million
June 30, 2025 1.8 million 8.9 million 23.5 million 15.6 million

BBNX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 27.6 million 11.2 million
Dec. 31, 2025 32.1 million 13.2 million
Sept. 30, 2025 27.3 million 12.1 million
June 30, 2025 23.2 million 10.7 million

BBNX

Price: $13.73

52 week price:
8.80
32.71

Earnings Per Share: -1.37 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 554.8 million

Links: